Macroautophagy (commonly called autophagy) is the cell's bulk recycling system. It engulfs damaged organelles, protein aggregates, and even invading pathogens inside double-membrane vesicles called autophagosomes, which then fuse with lysosomes for degradation. The 2016 Nobel Prize in Physiology recognized Yoshinori Ohsumi's pioneering work on this pathway.
The Autophagy Pathway
Autophagy proceeds through a stepwise membrane remodeling process. First, the ULK1 complex initiates phagophore nucleation at the ER membrane. The Beclin-1/VPS34 complex generates PI3P to recruit downstream effectors. LC3 protein is lipidated to LC3-II and inserted into the growing phagophore membrane, serving as both a structural component and a cargo receptor. The phagophore elongates, curves around its target, and seals to form a complete autophagosome.
Key Regulatory Mechanisms
- mTOR -- the Master Inhibitor: When nutrients are abundant, mTOR phosphorylates and inhibits ULK1, suppressing autophagy. Starvation inactivates mTOR, unleashing the autophagic response.
- Selective Autophagy: Specific receptors target particular cargo -- mitophagy (damaged mitochondria via PINK1/Parkin), xenophagy (intracellular bacteria), and aggrephagy (protein aggregates via p62/SQSTM1).
- Lysosomal Fusion: Autophagosomes fuse with lysosomes via SNARE proteins, forming autolysosomes where acidic hydrolases degrade the contents into amino acids, lipids, and sugars for reuse.
Why It Matters
Autophagy is essential for cellular housekeeping, starvation survival, and immune defense. Defective autophagy is linked to neurodegeneration, cancer, infections, and aging. Pharmacological modulation of autophagy is an active area of therapeutic research.
Category: Biochemistry & Molecular Biology — Cellular recycling and organelle quality control